Inhibitory effects of antihistamines, diphenhydramine and chlorpheniramine, on proton currents in BV2 microglial cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jiwon | - |
dc.contributor.author | Song, Jin-Ho | - |
dc.date.available | 2019-03-08T09:36:01Z | - |
dc.date.issued | 2017-03 | - |
dc.identifier.issn | 0014-2999 | - |
dc.identifier.issn | 1879-0712 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/4694 | - |
dc.description.abstract | Microglial NADPH oxidase is a major source of toxic reactive oxygen species produced during chronic neuroinflammation. Voltage-gated proton channel (H(v)1) functions to maintain the intense activity of NADPH oxidase, and channel inhibition alleviates the pathology of neurodegenerative diseases such as ischemic stroke and multiple sclerosis associated with oxidative neuroinflammation. Antagonists of histamine H-1 receptors have beneficial effects against microglia-mediated oxidative stress and neurotoxicity. We examined the effects of the H-1 antihistamines, diphenhydramine and chlorpheniramine, on proton currents in BV2 microglial cells recorded using the whole-cell patch clamp technique. Diphenhydramine and chlorpheniramine reduced the proton currents with almost the same potency, yielding IC50 values of 42 and 43 mu M, respectively. Histamine did not affect proton currents, excluding the involvement of histamine receptors in their action. Neither drug shifted the voltage-dependence of activation or the reversal potential of the proton currents, even though diphenhydramine slowed the activation and deactivation kinetics. The inhibitory effects of the two antihistamines on proton currents could be utilized to develop therapeutic agents for neurodegenerative diseases and other diseases associated with H(v)1 proton channel abnormalities. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.title | Inhibitory effects of antihistamines, diphenhydramine and chlorpheniramine, on proton currents in BV2 microglial cells | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.ejphar.2017.01.032 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF PHARMACOLOGY, v.798, pp 122 - 128 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000397551200016 | - |
dc.identifier.scopusid | 2-s2.0-85011292126 | - |
dc.citation.endPage | 128 | - |
dc.citation.startPage | 122 | - |
dc.citation.title | EUROPEAN JOURNAL OF PHARMACOLOGY | - |
dc.citation.volume | 798 | - |
dc.type.docType | Article | - |
dc.publisher.location | 네델란드 | - |
dc.subject.keywordAuthor | Antihistamines | - |
dc.subject.keywordAuthor | Chlorpheniramine | - |
dc.subject.keywordAuthor | Diphenhydramine | - |
dc.subject.keywordAuthor | Histamine | - |
dc.subject.keywordAuthor | Microglia | - |
dc.subject.keywordAuthor | Proton channel | - |
dc.subject.keywordPlus | PHAGOCYTE RESPIRATORY BURST | - |
dc.subject.keywordPlus | NADPH OXIDASE | - |
dc.subject.keywordPlus | SUPEROXIDE-PRODUCTION | - |
dc.subject.keywordPlus | CHANNEL HV1 | - |
dc.subject.keywordPlus | CHRONIC NEUROINFLAMMATION | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | VOLTAGE SENSOR | - |
dc.subject.keywordPlus | HISTAMINE | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | EOSINOPHILS | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.